Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study

Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands

(2015) Marinus J.C. Eijkemans et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Differentiation of Sporadic Versus Tuberous Sclerosis Complex–Associated Angiomyolipoma

(2015) Rahmin A. Rabenou et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Everolimus for subependymal giant cell astrocytoma: 5-year final analysis

(2015) David N. Franz et al.   ANNALS OF NEUROLOGY

Complications of mammalian target of rapamycin inhibitor anticancer treatment among patients with tuberous sclerosis complex are common and occasionally life-threatening

(2015) Joanna Trelinska et al.   ANTI-CANCER DRUGS

Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial

(2015) John J. Bissler et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

(2013) John J Bissler et al.   LANCET

Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma

(2013) D. A. Krueger et al.   NEUROLOGY

Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

(2013) Darcy A. Krueger et al.   PEDIATRIC NEUROLOGY

mTOR Inhibitors in Tuberous Sclerosis Complex

(2012) Paolo Curatolo et al.   Current Neuropharmacology

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

(2012) David Neal Franz et al.   LANCET

Tuberous Sclerosis Complex–Associated Angiomyolipomas: Focus on mTOR Inhibition

(2011) Klemens Budde et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis

(2011) Francis X. McCormack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis

(2010) Darcy A. Krueger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated

(2009) Prasanna Sooriakumaran et al.   BJU INTERNATIONAL

Tuberous sclerosis

(2008) Paolo Curatolo et al.   LANCET